Volume | 148,329 |
|
|||||
News | - | ||||||
Day High | 2.04 | Low High |
|||||
Day Low | 1.92 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Context Therapeutics Inc | CNTX | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
2.00 | 1.92 | 2.04 | 2.03 | 1.99 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
1,235 | 148,329 | $ 2.02 | $ 298,979 | - | 0.6001 - 2.10 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:19:50 | 1 | $ 2.03 | USD |
Context Therapeutics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
32.41M | 15.97M | - | 0 | -23.96M | -1.50 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Context Therapeutics News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CNTX Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.66 | 2.10 | 1.6301 | 1.87 | 398,410 | 0.37 | 22.29% |
1 Month | 1.40 | 2.10 | 1.30 | 1.76 | 1,607,656 | 0.63 | 45.00% |
3 Months | 1.11 | 2.10 | 1.03 | 1.72 | 593,001 | 0.92 | 82.88% |
6 Months | 0.90 | 2.10 | 0.77 | 1.67 | 305,425 | 1.13 | 125.56% |
1 Year | 0.64 | 2.10 | 0.6001 | 1.55 | 195,885 | 1.39 | 217.19% |
3 Years | 4.44 | 10.87 | 0.47 | 3.82 | 850,591 | -2.41 | -54.28% |
5 Years | 4.44 | 10.87 | 0.47 | 3.82 | 850,591 | -2.41 | -54.28% |
Context Therapeutics Description
Context Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to improving the lives of women living with cancer. The development team is advancing a pipeline of innovative therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. |